Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
[Novel strategies of ovarian cancer treatment]
Katarzyna Duda1, Hanna Cholewa1, Krzysztof Łabuzek1
1Silesian University of Medicine in Katowice, Poland: Department of Internal Diseases and Clinical Pharmacology.
Abstract:
Ovarian cancer is the most lethal gynecological malignancy. Due to scarce specific symptoms, women usually seek medical help once the disease is highly advanced, with distant metastases. Currently no screening is available, making this particular cancer hard to detect in the early stage. Standard treatment is insufficient for many patients, especially in the recurrent disease. This fact explains the tremendous need to search for novel therapeutic approaches. Inhibition of angiogenesis and destruction of cancer stem cells are attempts that affect the tumor microenvironment. There is a lot of potential in inhibiting poly(ADP-rybose)polymerase (PARP) or I class histone deacetylase. Drug repositioning may also be beneficial, as it gives old drugs new purposes. Metformin, a well-known antidiabetic agent, is an example of this phenomenon. Constant progress in medicine and science makes us hope for positive outcomes while treating this highly dangerous disease.
Insights
Ovarian cancer is a deadly gynecological malignancy often detected late due to vague symptoms. Novel therapies targeting tumor microenvironment and drug repositioning, like metformin, offer hope for improved treatment outcomes.
Area of Science:
- Gynecologic Oncology
- Medical Research
Context:
- Ovarian cancer is the leading cause of gynecological cancer death.
- Late-stage diagnosis is common due to non-specific symptoms and lack of screening.
- Current treatments are often insufficient for recurrent disease.
Purpose:
- To explore novel therapeutic strategies for ovarian cancer.
- To investigate approaches targeting the tumor microenvironment.
- To evaluate the potential of drug repositioning for ovarian cancer treatment.
Summary:
- Research focuses on new ovarian cancer treatments, including inhibiting angiogenesis and targeting cancer stem cells.
- Inhibiting poly(ADP-ribose) polymerase (PARP) and class I histone deacetylase are promising avenues.
- Drug repositioning, exemplified by the antidiabetic agent metformin, is being explored.
Impact:
- Advances in understanding and treating ovarian cancer are crucial.
- Novel therapeutic approaches aim to improve outcomes for patients with this lethal disease.
- Continued scientific progress offers hope for more effective ovarian cancer management.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Treatment Resistent Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Tumor Immunotherapy

